PROPHYLACTIC OR THERAPEUTIC AGENT FOR AXIAL MYOPIA

摘要

High myopia increases the risk of retinal detachment, myopic chorioretinal atrophy, myopic choroidal neovascularization, glaucoma and cataract.  Therefore, it is expected to establish a method for preventing the progression of myopia.  For axial myopia which is believed to cause high myopia, however, there is no effective prophylactic or therapeutic method at present.  It is now found that a Rho kinase inhibitor has an activity to inhibit the elongation of a visual axis.  Thus, disclosed is a pharmaceutical agent having an excellent prophylactic or therapeutic effect on axial myopia, which comprises a Rho kinase inhibitor as an active ingredient.